Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCT

<strong>Trial design<br></strong> A randomised, parallel-group, double-blind, placebo-controlled multicentre study with health economic and nested qualitative studies to determine if mifepristone (Mifegyne®, Exelgyn, Paris, France) plus misoprostol is superior to misoprostol alone...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar:	Devall, A, Chu, J, Beeson, L, Hardy, P, Cheed, V, Sun, Y, Roberts, T, Ogwulu, CO, Williams, E, Jones, L, Papadopoulos, JLF, Bender-Atik, R, Brewin, J, Hinshaw, K, Choudhary, M, Ahmed, A, Naftalin, J, Nunes, N, Oliver, A, Izzat, F, Bhatia, K, Hassan, I, Jeve, Y, Hamilton, J, Deb, S, Bottomley, C, Ross, J, Watkins, L, Underwood, M, Cheong, Y, Kumar, C, Gupta, P, Small, R, Pringle, S, Hodge, F, Shahid, A, Gallos, I, Horne, A, Quenby, S, Coomarasamy, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	NIHR Journals Library 2021

Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCT

Benzer Materyaller